Colorectal DisordersRICARTNCT03862781
Intra-Corporeal Anastomosis Result in Quicker Return of Bowel Function/Earlier Discharge
A study testing Right Hemicolectomy in people with Colorectal Disorders, run by Corewell Health West at 1 site in United States.
Trial summary
Adult patients who are regularly scheduled to undergo a right hemicolectomy via a minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Colorectal Disorders
- What is being tested?
- Right Hemicolectomy
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 125 participants
- Where
- 1 siteUnited States
- Study dates
- 28 Jan 2019to Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Eligible patients are those over 18 years of age who are regularly scheduled to undergo a right hemicolectomy via a minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis. Right colectomy will be defined as removal of the ascending colon, ligation of the ileocolic artery and vein, +/- removal of the terminal ileum, +/- removal of the proximal transverse colon, and +/- removal of the right branch of the middle colic artery and vein.
Who cannot join
- Pregnant women
- Additional colon resection is planned (i.e. left colectomy or proctectomy)
- Vulnerable populations such as prisoners or adults unable to give consent
- If the scheduled surgery is planned at Butterworth hospital (as to standardize the nursing care received postoperatively)
- Emergent cases
- Patients will be excluded from the study intra-operatively if:
- The procedure is converted to an open resection
- If a loop ileostomy is performed in addition to the right colectomy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Ellen Derrer contact
United States1 site, 1 recruiting
- Recruiting
Corewell Health Medical Group
Grand Rapids, Michigan, 49546
Julia E reish, 616-486-2022, Julia.reish@corewellhealth.org
Rachel R Gross, rachel.gross@corewellhealth.org
About this study
Official title: Randomized Trial of Intra-Corporeal Anastomosis for RighT Colectomies (RICART Study)
Adult patients who are regularly scheduled to undergo a right hemicolectomy via a minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis.
Read the detailed description
The purpose of this trial is to investigate whether minimally invasive right colectomies done with an intra-corporeal anastomosis result in quicker return of bowel function and earlier discharge. The primary endpoint of this study will be return of bowel function as measured by passage of flatus and bowel motions. The secondary endpoints will be inpatient length of stay, incision length, postoperative narcotic use, surgical site infection (superficial, deep and organ-space), perioperative morbidity and operating room charges.
- Conditions
- Colorectal Disorders
- Being tested
- Right Hemicolectomy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Right HemicolectomyProcedure or surgery
Minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis.
| Study group | Role | What they receive |
|---|---|---|
| Intra-corporeal | Other | Right Hemicolectomy Receives: Procedure: Right Hemicolectomy |
| Extra-corporeal | Other | Right Hemicolectomy Receives: Procedure: Right Hemicolectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Return of bowel function
Flatus and bowel motions
Measured: up to 2 weeks
Secondary outcomes (6)
Inpatient length of stay
Days in the hospital after surgery
Measured: up to 2 weeks
Incision length
cm's
Measured: Surgery date
Postoperative narcotic use
Average pain scores over first 5 hospital days
Measured: up to 2 weeks
Surgical site infection
(superficial, deep and organ-space)
Measured: up to 6 weeks
Perioperative morbidity
Disease state
Measured: Baseline (Prior to surgery)
Operating room charges
Fees for operating room
Measured: Surgery date
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Mar 2019
- Study start28 Jan 2019
- Primary completionDec 2026 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Colorectal DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- After the participants have been consented to the study, the study coordinator will refer to the randomization schedule, and alert the surgeon whether creation of the anastomosis will be done in either an intra-corporeal or extra-corporeal fashion.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 125 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Corewell Health West
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, James W. Ogilvie, Corewell Health West
- Investigators
- James W Ogilvie, Jr., MS, Principal investigator, Corewell Health West
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03862781
- Sponsor's protocol ID
- 2018-139
- Acronym
- RICART
- Status last verified
- Jul 2026
- First submitted
- 5 Feb 2019
- Last updated
- 20 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is no plan to Share IPD.
Study at a glance
From the registry record, last updated by the sponsor on 20 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Randomized Trial of Intra-Corporeal Anastomosis for RighT Colectomies (RICART Study)
- ClinicalTrials.gov ID
- NCT03862781
- Acronym / sponsor ID
- RICART / 2018-139
- Conditions
- Colorectal Disorders
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 125 participants (estimated)
- Lead sponsor
- Corewell Health WestUniversity, hospital or other
- Study start
- 28 Jan 2019 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 5 Mar 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Adult patients who are regularly scheduled to undergo a right hemicolectomy via a minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis.
Detailed description
The purpose of this trial is to investigate whether minimally invasive right colectomies done with an intra-corporeal anastomosis result in quicker return of bowel function and earlier discharge. The primary endpoint of this study will be return of bowel function as measured by passage of flatus and bowel motions. The secondary endpoints will be inpatient length of stay, incision length, postoperative narcotic use, surgical site infection (superficial, deep and organ-space), perioperative morbidity and operating room charges.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- After the participants have been consented to the study, the study coordinator will refer to the randomization schedule, and alert the surgeon whether creation of the anastomosis will be done in either an intra-corporeal or extra-corporeal fashion.
| Arm | Type | Receives |
|---|---|---|
| Intra-corporeal | Other | Procedure: Right HemicolectomyRight Hemicolectomy |
| Extra-corporeal | Other | Procedure: Right HemicolectomyRight Hemicolectomy |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Eligible patients are those over 18 years of age who are regularly scheduled to undergo a right hemicolectomy via a minimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis. Right colectomy will be defined as removal of the ascending colon, ligation of the ileocolic artery and vein, +/- removal of the terminal ileum, +/- removal of the proximal transverse colon, and +/- removal of the right branch of the middle colic artery and vein.
Key exclusion criteria (8 listed)
- Pregnant women
- Additional colon resection is planned (i.e. left colectomy or proctectomy)
- Vulnerable populations such as prisoners or adults unable to give consent
- If the scheduled surgery is planned at Butterworth hospital (as to standardize the nursing care received postoperatively)
- Emergent cases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Right HemicolectomyMinimally invasive approach (robotic or laparoscopic) with the creation of an anastomosis. | Procedure or surgery | Extra-corporeal, Intra-corporeal |
Primary outcome
Return of bowel function
Time frame: up to 2 weeks
Flatus and bowel motions
6 secondary outcomes
Inpatient length of stay
Time frame: up to 2 weeks
Incision length
Time frame: Surgery date
Postoperative narcotic use
Time frame: up to 2 weeks
Surgical site infection
Time frame: up to 6 weeks
Perioperative morbidity
Time frame: Baseline (Prior to surgery)
Operating room charges
Time frame: Surgery date
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Jul 2026.
- Individual participant dataSharing planned: No. There is no plan to Share IPD.
Related trials for Colorectal Disorders
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingObservational study
Pre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer
Rectal Neoplasms
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ellen Derrer contact
James W Ogilvie, Jr., MS principal investigator
Corewell Health West
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Right Hemicolectomy in people with Colorectal Disorders, run by Corewell Health West at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact kendra Selby (616-486-0281, kendra.selby@helendevoschidrens.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Return of bowel function (time frame: up to 2 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2026; AzTrials last refreshed its copy on 7 Nov 2026.